pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·May 11·1 min read
save

President Trump says government may consider approving certain forms of kratom-derived 7-OH

May 11, 2026·read at STAT ↗RegulatoryNeutral

President Trump suggested the federal government could move to approve some forms of 7-OH, an opioid derived from the kratom plant.

7-OH, short for 7-hydroxymitragynine, occurs naturally in kratom, which is used recreationally and as an unapproved pain treatment. While it is less dangerous than synthetic opioids such as fentanyl, it still poses risks of addiction and overdose.

The FDA previously warned that natural opioids in kratom were being turned into harmful products. Trump's remarks did not clarify what “natural 7-OH” refers to or outline a specific regulatory pathway.

No concrete steps or timeline were announced, leaving uncertainty about any formal approval process.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Trump pivots on kratom derivative 7-OH, floating approval for some forms”

read at STAT ↗
387 words · retrieved May 11
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

drugs
FENTANYL-372FENTANYL-752fentanyl2fentanyl CR2fentanyl ER2MIFEPRISTONE
topics
Approval4Pain4

related stories

  • Sep 30Kratom and 7-OH should be regulated, experts agree. They’re split on howSTAT
  • Sep 21President Trump’s newest vaccine ‘demands’ repeat old misinformationSTAT
  • Sep 21Addiction clinics see rising cases of kratom and 7-OH withdrawalSTAT
  • Sep 16U.S. reaches highest number of measles deaths in decadesSTAT
  • Aug 25STAT+: AI is good at catching drug theft at hospitals, but only when humans do their partSTAT